Page 7 - ஜோசபின் கொத்தனார் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜோசபின் கொத்தனார். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜோசபின் கொத்தனார் Today - Breaking & Trending Today

EXCLUSIVE Sanofi offers to buy U.S. biotech, mRNA partner Translate Bio -sources


Sanofi board discussed deal on Sunday
U.S. biotech company s shares soar more than 70% after report
Financial terms not known
PARIS, Aug 2 (Reuters) - Sanofi (SASY.PA) has offered to buy U.S. biotech company Translate Bio (TBIO.O), two sources familiar with the situation said on Monday, as the French drugmaker bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race.
Shares in the New York-listed biotech company soared more than 70% to above $50 in extended trading, building on the big gains in the stock as investors have piled in to the sector amid a rush to develop vaccines and treatments to tame the pandemic which has killed 4.3 million and roiled the global economy. ....

New York , United States , France General , Josephine Mason , Paul Hudson , Lewis Krauskopf , Matthias Blamont , Matthew Lewis , Ankur Banerjee , Caroline Humer , Thomson Reuters Trust Principles , Translate Bio , New York Listed , Paris Additional , Thomson Reuters Trust , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஜோசபின் கொத்தனார் , பால் ஹட்சன் , லெவிஸ் க்ரோுஸ்கோப்ப் , மேத்யூ லெவிஸ் , அன்குர் பானர்ஜி , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , மொழிபெயர் உயிர் , புதியது யார்க் பட்டியலிடப்பட்டுள்ளது , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ,

Sanofi offers to buy U.S. biotech, mRNA partner Translate Bio -sources


Article content
TOUGH YEAR
Sanofi’s interest comes after a tough year for the French drugmaker after falling behind rivals with less experience in the COVID-19 vaccine race, a major blow to CEO Paul Hudson who joined the company almost two years ago.
Sanofi warned last year its traditional, protein-based COVID-19 jab developed with GlaxoSmithKline showed an insufficient immune response in older people, delaying its launch until toward the end of 2021.
Hudson has also been under increasing pressure to reduce the company’s dependence on its star eczema treatment Dupixent to boost earnings. Earlier this year, it agreed to fill and pack millions of doses of shots made by Pfizer/BioNTech, Johnson & Johnson and Moderna. ....

New York , United States , France General , Josephine Mason , Paul Hudson , Lewis Krauskopf , Matthias Blamont , Matthew Lewis , Ankur Banerjee , Caroline Humer , Postmedia Network Inc , Translate Bio , New York Listed , Paris Additional , Postmedia Network , Street East , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஜோசபின் கொத்தனார் , பால் ஹட்சன் , லெவிஸ் க்ரோுஸ்கோப்ப் , மேத்யூ லெவிஸ் , அன்குர் பானர்ஜி , மொழிபெயர் உயிர் , புதியது யார்க் பட்டியலிடப்பட்டுள்ளது , தெரு கிழக்கு ,

Delta variant spreads 'like wildfire' as doctors study whether it makes patients sicker


Published Monday, August 2, 2021 11:03PM EDT
LOS ANGELES, Aug 2 (Reuters) - With a new wave of COVID-19 infections fueled by the Delta variant striking countries worldwide, disease experts are scrambling to learn whether the latest version of coronavirus is making people - mainly the unvaccinated - sicker than before.
The U.S. Centers for Disease Control and Prevention warned that Delta, first identified in India and now dominant worldwide, is likely more severe than earlier versions of the virus, according to an internal report made public on Friday.
The agency cited research in Canada, Singapore and Scotland showing that people infected with the Delta variant were more likely to be hospitalized than patients earlier in the pandemic. ....

United States , United Kingdom , San Diego , City Of , David Montefiori , Shane Crotty , Michele Gershberg , Julie Steenhuysen , Deena Beasley , Lawrence Young , Benjamin Barlow , Daniel Wallis , Josephine Mason , Los Angeles , Michelle Barron , Us Centers For Disease , Duke University Medical Center , Jolla Institute For Immunology , United Kingdom Warwick Medical School , Vaccine Research , Disease Control , Warwick Medical , Gregory Poland , American Family Care , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் ,

Sanofi to buy U.S. mRNA partner Translate Bio in $3.2 billion deal


Sanofi to buy U.S. mRNA partner Translate Bio in $3.2 billion deal
By Matthias Blamont
Reuters
PARIS (Reuters) -Sanofi has agreed to buy U.S. biotech company Translate Bio in a $3.2 billion deal, as it bets on next-generation mRNA technology after setbacks in the COVID-19 vaccine race, confirming a Reuters exclusive report.
Sanofi said it would acquire all outstanding shares of Translate Bio for $38.00 per share in cash, representing a total equity value of about $3.2 billion for Translate Bio.
The boards of both companies have approved the deal, and the chief executive of Translate Bio and the U.S. company s largest shareholder have backed the takeover offer, Sanofi and Translate Bio said in a joint statement. ....

New York , United States , France General , Sudip Kar Gupta , Matthew Lewis , Sonali Paul , Josephine Mason , Paul Hudson , Lewis Krauskopf , Matthias Blamont , Ankur Banerjee , Caroline Humer , Morgan Stanley , Translate Bio , Sanofi Chief Executive Paul , Centerview Partners , Louise Heavens , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சூடிப் கர் குப்தா , மேத்யூ லெவிஸ் , சொனாலி பால் , ஜோசபின் கொத்தனார் , பால் ஹட்சன் , லெவிஸ் க்ரோுஸ்கோப்ப் , அன்குர் பானர்ஜி ,